FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis Along with AbbVie Inc's (NYSE: ABBV) Benzinga · Jan 18, 2022
Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed Health Canada approved Pfizer Inc's (NYSE: PFE) oral antiviral treatment for mild to moderate cases of COVID-19 in adults. Benzinga · Jan 18, 2022
Macron Touts Rosy French Economy, New Jobs Ahead of Election President Emmanuel Macron on Monday touted 21 new foreign investment projects in France and a booming economy as proof his economic reforms have been bearing fruit less than three months before a presidential election in which he is expected to run. During a visit to Alsace in the east, Macron… Asharq Al-Awsat · Jan 17, 2022
Why getting boosted is a pain in the arm Have you had "Pfizer boob" after COVID booster? Newcastle Herald · Jan 17, 2022
Israeli Study Shows 4th Shot of COVID-19 Vaccine Less Effective on Omicron A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron infections, according to a preliminary study in Israel. Israel's Sheba Medical Center has given second booster shots in a trial among its staff and is studying… Asharq Al-Awsat · Jan 17, 2022
Latest COVID updates: Canada approves Pfizer COVID pill COVID news from January 17: Canada authorises pill for adults with mild, moderate COVID who are at high risk. Al Jazeera · Jan 17, 2022